Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)

The ErbB family of receptor tyrosine kinases comprises four members: epidermal growth factor receptor (EGFR/ErbB1), human EGFR 2 (HER2/ErbB2), ErbB3/HER3, and ErbB4/HER4. The first two members of this family, EGFR and HER2, have been implicated in tumorigenesis and cancer progression for several dec...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:NPJ Syst Biol Appl
Główni autorzy: Schoeberl, Birgit, Kudla, Art, Masson, Kristina, Kalra, Ashish, Curley, Michael, Finn, Gregory, Pace, Emily, Harms, Brian, Kim, Jaeyeon, Kearns, Jeff, Fulgham, Aaron, Burenkova, Olga, Grantcharova, Viara, Yarar, Defne, Paragas, Violette, Fitzgerald, Jonathan, Wainszelbaum, Marisa, West, Kip, Mathews, Sara, Nering, Rachel, Adiwijaya, Bambang, Garcia, Gabriela, Kubasek, Bill, Moyo, Victor, Czibere, Akos, Nielsen, Ulrik B, MacBeath, Gavin
Format: Artigo
Język:Inglês
Wydane: Nature Publishing Group 2017
Hasła przedmiotowe:
Review Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5516865/
https://ncbi.nlm.nih.gov/pubmed/28725482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjsba.2016.34
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy